Avid Bioservices Inc (CDMO)

[biopharm]

Anyone see the future of Avid Bioservices / MSK / Parker Instititue of Cancer Immunotherapy converging ?

Biological Processing to Reduce Drug Development Timelines and Bring Therapies to Market Faster

The Beacon Platform Combines Biology and Engineering to Shorten Biopharmaceutical Processes from Months to Days

....
.....
The digitization of biology coupled with increasing computational power and application of deep learning has paved the way for new and improved therapies. However, we need a way to deliver these therapies in a cost-effective and rapid manner and further increase access to all patients," said Michael Moritz, Partner, Sequoia Capital. "By combining the best of engineering with the world of biology, Berkeley Lights is helping companies achieve this with an automated platform that frees biologists from manual tasks to focus on discovering new treatments."

The integration of automation into the drug discovery workflow has the potential to reduce standard development timelines from 15 years to less than five years.1 Each day saved in the development of these therapies equates to reduced overall development costs and earlier patient access to vital drugs. Today Berkeley Lights' customers are using the Beacon platform to accelerate biological workflows, specifically for large molecule therapies.

The company is also applying its technology to diagnostics and cell therapy manufacturing for personalized medicine. Rapid advances in CAR-T, CRISPR based gene editing and other new discoveries enable human immune cell modification to combat cancer and show great promise. However, because these therapies use the patient's own immune cells, they are complex to discover, costly to manufacture and many patients go untreated.

"Berkeley Lights' technology gives scientists the ability to see, interact and automate biological processing to dramatically improve the speed and efficiency of research and development," said Eric Hobbs, PhD, CEO, Berkeley Lights. "Modern medicine is experiencing a biological revolution where new therapies that are able to combat complex disease are advancing rapidly. Our platforms provide the scale, speed, and cost efficiencies needed to accelerate these advances with the ultimate goal of providing access to life changing therapies for all patients."

...

...
https://www.prnewswire.com/news-releases/berkeley-lights-automates-biological-processing-to-reduce-drug-development-timelines-and-bring-therapies-to-market-faster-300517261.html